UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
FORM 12b-25
 
NOTIFICATION OF LATE FILING
 
SEC FILE NUMBER 333-173039
CUSIP NUMBER   42225M102

(Check One) :    o Form 10-K    o Form 20-F    x Form 10-Q    o Form 10-D     o Form N-SAR

For Period Ended:       March 31, 2014                                
  Transition Report on Form 10-K
  Transition Report on Form 20-F
  Transition Report on Form 11-K
  Transition Report on Form 10-Q
  Transition Report on Form N-SAR
For the Transition Period Ended:                                        

Read Instruction (on back page) Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein .
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
     
 
PART I -- REGISTRANT INFORMATION
 
Health Revenue Assurance Holdings, Inc.
Full Name of Registrant
 
     
Former Name if Applicable
 
18551 W. Sunrise Boulevard, Ste. 304
Address of Principle Executive Office (Street and Number)
 
Plantation, FL 33322
City, State and Zip Code

PART II -- RULES 12B-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate)
 
x
(a)  The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b)  The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)  The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
 
 

 
 
PART III--NARRATIVE
 
State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
As previously reported, the Company recently acquired the services of a new interim Chief Executive Officer and Chief Financial Officer.  As a result, the new officers had a limited amount of time to prepare the Form 10-Q.  
 
PART IV--OTHER INFORMATION
 
(1)  
Name and telephone number of person to contact in regard to this notification
 
Gina Hicks
 
954
 
472-2340
(Name)
 
(Area Code)
 
(Telephone Number)

(2)  
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If the answer is no, identify report(s).
  x Yes   o No        

(3)  
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
  x Yes   o No        

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 

 
 
Health Revenue Assurance Holdings, Inc.      
(Name of Registrant as Specified in Charter)
 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date
May 15, 2014
By
/s/ Gina Hicks

INSTRUCTION:  The form may be signed by an executive officer or the registrant or by any other duly authorized representative.  The name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
 
 
 
 

 
 
 
Annex A

The Company anticipates reporting an operating loss of approximately $1.2 million for the three months ended March 31, 2014 as compared to approximately $300,000 for the three months ended March 31, 2013.
 
 
 
Health Revenue Assuance (PK) (USOTC:HRAA)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Health Revenue Assuance (PK) Charts.
Health Revenue Assuance (PK) (USOTC:HRAA)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Health Revenue Assuance (PK) Charts.